IMD International Medical Devices SpA (MIL:IMD) EBIT: €1.91 Mil (TTM As of Dec. 2025)


MIL:IMD IMD International Medical Devices SpA MIL:IMD
44 GF Score
Price €1.28
GF Value €1.35
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is IMD International Medical Devices SpA EBIT?

IMD International Medical Devices SpA MIL:IMD -2.29% 44 EBIT is €1.91 Mil as of Dec. 2025. GuruFocus rates MIL:IMD with a GF Score™ of 44/100 and a GF Value™ of €1.35 (Fairly Valued). The stock has 3 warning signs investors should review.

IMD International Medical Devices SpA's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €1.19 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €1.91 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. IMD International Medical Devices SpA's annualized ROC % for the quarter that ended in Dec. 2025 was 11.08%. IMD International Medical Devices SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 15.43%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. IMD International Medical Devices SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 13.57%.

IMD International Medical Devices SpA  (MIL:IMD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

IMD International Medical Devices SpA's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=2.598 * ( 1 - 19.86% )/( (20.099 + 17.478)/ 2 )
=2.0820372/18.7885
=11.08 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=33.216 - 7.346 - ( 5.771 - max(0, 9.199 - 30.583+5.771))
=20.099

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=32.893 - 7.063 - ( 8.352 - max(0, 8.14 - 30.531+8.352))
=17.478

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

IMD International Medical Devices SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2.378/( ( (0.669 + max(15.473, 0)) + (0.659 + max(14.026, 0)) )/ 2 )
=2.378/( ( 16.142 + 14.685 )/ 2 )
=2.378/15.4135
=15.43 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.545 + 15.053 + 2.901) - (7.346 + 0 + 1.68)
=15.473

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7.278 + 12.41 + 2.296) - (7.063 + 0 + 0.895)
=14.026

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

IMD International Medical Devices SpA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=1.908/14.059
=13.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMD International Medical Devices SpA EBIT Related Terms

IMD International Medical Devices SpA EBIT Historical Data

* Premium members only.

The historical data trend for IMD International Medical Devices SpA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMD International Medical Devices SpA EBIT Chart

IMD International Medical Devices SpA Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
7.17 4.93 3.69 3.30 1.91

IMD International Medical Devices SpA Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial 1.77 2.12 1.19 0.72 1.19

MIL:IMD vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, IMD International Medical Devices SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IMD International Medical Devices SpA EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IMD International Medical Devices SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where IMD International Medical Devices SpA's EV-to-EBIT falls into.


MIL:IMD
44GF Score
IMD International Medical Devices SpA MIL:IMD
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IMD International Medical Devices SpA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €1.91 Mil mean?
IMD International Medical Devices SpA (MIL:IMD) has a EBIT of €1.91 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on IMD International Medical Devices SpA.
Is IMD International Medical Devices SpA's EBIT too high?
IMD International Medical Devices SpA's current EBIT is €1.91 Mil. Overall, IMD International Medical Devices SpA has a GF Score™ of 44/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IMD International Medical Devices SpA's EBIT compare to ABT and SYK?
IMD International Medical Devices SpA's EBIT of €1.91 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on IMD International Medical Devices SpA. IMD International Medical Devices SpA's current EBIT is €1.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMD International Medical Devices SpA stock overvalued right now?
Based on GuruFocus' analysis, IMD International Medical Devices SpA (MIL:IMD) is currently considered Fairly Valued. The stock's GF Value™ is €1.35, compared to a current price of €1.28 — trading 5.2% below its estimated fair value. The current EBIT is €1.91 Mil. IMD International Medical Devices SpA's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For IMD International Medical Devices SpA (MIL:IMD), the current EBIT is €1.91 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IMD International Medical Devices SpA (MIL:IMD) Overvalued in 2026?

Based on GuruFocus' analysis, IMD International Medical Devices SpA stock appears to be undervalued. The current stock price of €1.28 is trading 5.2% below its estimated GF Value™ of €1.35. GuruFocus considers IMD International Medical Devices SpA to be Fairly Valued.

Key valuation signals for MIL:IMD:

  • EBIT: €1.91 Mil
  • GF Value™: €1.35 vs. price of €1.28 (5.2% below fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the MIL:IMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IMD International Medical Devices SpA Business Description

Address Via E. Fermi 26, Grassobbio, ITA, 24050
IMD International Medical Devices SpA is a company manufacturing X-ray medical equipment with a complete range of mobile imaging systems.
44GF Score

Get the complete analysis for MIL:IMD

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.28
Price
€1.35
GF Value